Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
SPDR S&P International Industrial Sector ETF (NY: IPN)
29.14 USD  +0.16 (+0.55%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Fund Documents
All news about SPDR S&P International Industrial Sector ETF
 
< Previous 1 2 3 4 5 Next >
Ipsen’s First Quarter 2013 Sales
April 25, 2013
from Business Wire News Releases
Ipsen expects Increlex® supply interruption due to supplier manufacturing issues
April 25, 2013
from Business Wire News Releases
Active Biotech and Ipsen Update the Analysis Plan for the 10TASQ10 Trial Evaluating Tasquinimod in the Treatment of Prostate Cancer
April 25, 2013
from Business Wire News Releases
Combined Shareholders’ Meeting of Ipsen on 31 May 2013: Proposals of Renewal of the Terms of Office of Two Directors and Appointment of a New Director
April 24, 2013
from Business Wire News Releases
PeptiDream and Ipsen Enter into a Collaboration for Advancing Drug Discovery Efforts for Peptides to Treat Serious Disease
April 10, 2013
from Business Wire News Releases
The Ipsen Group Publishes Its 2012 Registration Document
March 27, 2013
from Business Wire News Releases
Ipsen and Inspiration Biopharmaceuticals announce closing of the sale of OBI-1 to Baxter International
March 21, 2013
from Business Wire News Releases
Ex-Div Reminder for Canadian National Railway Co. (CNR.CA)
March 01, 2013
On 3/5/13, Canadian National Railway Co. (CNR. Read More
category Stocks
from Market News Video
Ipsen's 2012 Results and 2013 Financial Objectives
February 27, 2013
from Business Wire News Releases
Christel Bories Joins Ipsen as Deputy Chief Executive Officer
February 27, 2013
from Business Wire News Releases
Ipsen and Inspiration Biopharmaceuticals Announce Closing of the IB1001 Sale to Cangene Corporation
February 20, 2013
from Business Wire News Releases
Eziclen® / Izinova® a New Product for Bowel Cleansing Successfully Completed European Decentralised Registration Procedure
February 07, 2013
from Business Wire News Releases
Ipsen and Inspiration Biopharmaceuticals enter into an Asset Purchase Agreement with Cangene Corporation on IB1001
February 06, 2013
from Business Wire News Releases
Ipsen’s Fourth Quarter and Full Year 2012 Sales
January 30, 2013
from Business Wire News Releases
Ipsen and Inspiration Biopharmaceuticals Enter into an Asset Purchase Agreement with Baxter International on OBI-1
January 24, 2013
from Business Wire News Releases
Teijin Pharma to Launch Ipsen's Somatuline® Subcutaneous Injection in the Treatment of Acromegaly and Pituitary Gigantism in Japan
January 17, 2013
from Business Wire News Releases
Ipsen's Corporate Agenda for 2013
January 03, 2013
from Business Wire News Releases
Oncodesign And the Laboratory for Neurobiology and Gene Therapy at The KU Leuven Enter into a Research Collaboration for Advancing Drug Discovery Efforts with Ipsen in Parkinson's Disease
December 18, 2012
from Business Wire News Releases
Active Biotech and Ipsen Announce Completion of Recruitment of Tasquinimod Clinical Phase III Study in Prostate Cancer
December 10, 2012
from Business Wire News Releases
Canadian National Railway Co. About To Put More Money In Your Pocket (CNR.CA)
December 04, 2012
On 12/6/12, Canadian National Railway Co. (CNR. Read More
category Stocks
from Market News Video
Canadian National Railway Co. About To Put More Money In Your Pocket (CNR.CA)
December 04, 2012
On 12/6/12, Canadian National Railway Co. (CNR) will trade ex-dividend, for its quarterly dividend of $0.375, payable on 12/31/12. Read More
category Dividends
from Dividend Channel
Ipsen and Galderma increase their collaboration for Dysport® in new territories
December 03, 2012
from Business Wire News Releases
Ipsen and Inspiration Biopharmaceuticals Announce That OBI-1 Has Received Fast Track Designation from FDA for Acquired Hemophilia A
November 20, 2012
from Business Wire News Releases
SPDR S&P International Industrial Sector (IPN) Shares Cross Above 200 DMA
November 19, 2012
In trading on Monday, shares of the SPDR S&P International Industrial Sector ETF (IPN) crossed above their 200 day moving average of $24.47, changing hands as high as $24.60 per share. SPDR S&P... Read More
category ETFs
from ETF Channel
XOP, IPN: Big ETF Outflows
November 12, 2012
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the SPDR S&P Oil & Gas Exploration & Production ETF (XOP),... Read More
category ETFs
from ETF Channel
Ipsen’s hemophilia partner, Inspiration Biopharmaceuticals, seeks Chapter 11 protection
October 31, 2012
from Business Wire News Releases
Ipsen’s third quarter and first nine months 2012 sales
October 29, 2012
from Business Wire News Releases
Ipsen US Awards up to $300,000 for Dystonia Fellowship Grants in 2013
October 23, 2012
from Business Wire News Releases
Pharma Company Begins Cancer Trials
October 22, 2012
Active Biotech's partner Ipsen is beginning trials with a drug previously only used for prostate cancer... Read More
from Wealth Daily
Ipsen to initiate a proof-of-concept study with tasquinimod in additional cancer indications
October 19, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here